Related Articles
Overexpression of microRNA‑130a predicts adverse prognosis of primary gastrointestinal diffuse large B‑cell lymphoma
Potential of the tumor‑derived extracellular vesicles carrying the miR‑125b‑5p target TNFAIP3 in reducing the sensitivity of diffuse large B cell lymphoma to rituximab
High expression of microRNA-200c predicts poor clinical outcome in diffuse large B-cell lymphoma
Annexin A5 inhibits diffuse large B-cell lymphoma cell invasion and chemoresistance through phosphatidylinositol 3-kinase signaling
Screening and identification of differentially expressed microRNAs in diffuse large B‑cell lymphoma based on microRNA microarray